Personalized Immune Cell Treatment NKCL Classic
As part of the policy pledge of the new government in 2022, in relation to fostering the advanced bioindustry, which is attracting attention as a growth engine industry, pharmaceutical and bio companies are announcing the latest biopharmaceutical manufacturing permits. This is interpreted as ‘legal ...
The prolonged COVID-19 has increased the importance of virus research worldwide. We have been affected by many viruses. Colds, which are now simply recognized, are also viruses. However, the perception of the virus is changing as we go through COVID-19, and the state's inability to play its role due ...
NKCL Bio Group Inc. announced on November 25 that it had won the Grand Prize in the ‘Innovation Sector’ award from the Minister of Small and Medium Venture Business. The Ministry of SMEs and Startups said, “NKCL Bio Group was highly evaluated for its contribution to the development of the Korean b...
NKCL Bio Group Inc. announced on the 25th that it had won awards in two categories, the Technology Innovation Division and the Innovation Division of the Ministry of SMEs and Startups, at the ‘9th 2022 TV Chosun Management Grand Awards’. It is an awards ceremony hosted by TV Chosun and sponsored by...
On the 9th, NKCL Bio Group announced that it had signed a business agreement in Vietnam with Eco smart global, which has a business infrastructure in Vietnam, in order to enter the Vietnamese market in earnest. Eco Smart Global is a Korean company specializing in distribution channels that conducts v...
On October 12th, the filming of Maeil Economy TV’s 'High Praise Company' was held at NKCL Bio Group. Maeil Business TV's 'High Praise Company' is a program that delivers useful information by introducing the outstanding technologies of companies leading the Korean economy, such as introducing the un...
On October 27th (Thursday), NKCLC, a blockchain operated by NKCL Bio Group and Encle Foundation, participated in Blockchain Week in Busan (BWB 2022). BWB 2022, hosted by Busan City and the Busan Blockchain Industry Association, is a blockchain-specialized event to be held following the last year's 'N...
NKCLC of NKCL Bio Group Inc. and Encle Foundation announced that they would participate in Blockchain Week in Busan (BWB 2022). BWB 2022 is a blockchain-specialized event held in Busan following last year’s ‘NFT Busan 2021’ and will be held for three days from October 27 (Thu) to 29 (Sat) at BEXCO...
NKCL Biogroup announced that it had presented the preclinical results of NK cell therapy at the '2022 International Conference: The Korean Society for Molecular and Cellular Biology' (KSMCB) on the 30th. The Korean Society for Molecular and Cellular Biology, a world-renowned academic conference on ce...
1. Brief introduction of your company and current status please. Hello. This is Shin, Dong-Hwa, the CEO and Chairman of NKCL Bio Group Inc. NKCL Bio Group Inc.(NKCL Bio Group) is a bio-specialized company that researches and develops NK cell culture technology based on its cell culture technology. NK...
